ArticlePostepy dermatologii i alergologii2025
Psoriatic itch from the patients' perspective: a cross-sectional study.
Article in Postepy dermatologii i alergologii, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Psoriasis is a chronic inflammatory skin disease that affects mental health and is often associated with itch. Aim: To investigate the influence of itch on the symptoms of anxiety, depression, quality of life, and stigmatization in psoriasis patients. Material and methods: The studied group included 106 adults with psoriasis (34% females; mean age: 42.1 ±13.0 years). Disease severity was evaluated using the Psoriasis Area and Severity Index (PASI). The itch intensity was assessed by a numerical rating scale (NRS) and 4-Item Itch Questionnaire (4-IIQ). Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires were utilized to estimate the severity of depression and anxiety, respectively, and so was the Hospital Anxiety and Depression Scale (HADS). Quality of life (QoL) was evaluated using the Dermatology Life Quality Index (DLQI), while stigmatization was studied by the 6-Item Stigmatization Scale (6-ISS). Results: Psoriasis patients with itch scored significantly higher ( Conclusions: Itch significantly impacts the quality of life and well-being of patients with psoriasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.